|
Out now: Salipro® goes Biacore™ systems - See the results of our collaboration with GE Healthcare on antibody binding to membrane proteins, detergent-free, in our Application Note (link)
Salipro Biotech receives “Groundbreaking Idea Grant” from the Swedish Innovation Agency for the development of therapeutic antibodies.
Salipro Biotech receives notice of allowance from U.S. Patent and Trademark Office relevant to its Salipro® technology for the stabilisation of drug targets
Meet us at the GE Healthcare DiPIA meeting in Boston (June 17-20), presenting a poster with the results of our collaboration with GE Healthcare.
Salipro® for functional studies of a GPCR with NMR. Half-life of GPCR in Salipro® extended from 1.5 to 30 days. Check out the latest paper on our technology by Nietlispach et al: http://pubs.acs.org/doi/10.1021/jacs.7b06730
CEO Jens Frauenfeld invited speaker at the 10th Annual Proteins & Antibodies Congress in London.
Salipro Biotech is recipient of the Ingemar Croon Award 2017 (2 MSEK).
We're growing and moving to new premises in central Stockholm. With more lab space and offices, we're located at the Greenhouse Labs at the Royal Institute of Technology in Stockholm. Location
|
Categories |